1. B.B. Vargaftig, M. Chignard andJ. Benveniste,Present concepts on the mechanisms of platelet aggregation, Biochem. Pharmac.30, 263–271 (1981).
2. C.A. Demopoulos, G.E. Tsabikakis andV.M. Kapoulas,Intervascular pathobiology of acetyl glycerol ether phosphorycholine (AGEPC), a synthetic platelet-activating factor (PAF), Immunology Letters2, 133–135 (1981).
3. C.P. Page, W. Paul andJ. Morley,An in vivo model for studying platelet aggregation and disaggregation, Thrombos. Haemostas.47, 210–213 (1982).
4. A. Dewar, J. Morley, C.P. Page andW. Paul,In vivo properties of platelet activating factor (PAF-acether), J. Path. (in press).
5. C. Lalau Keraly, C. Tence, F. Heymans andJ. Benveniste,Specific desensitization of washed rabbit platelets by PAF-acether and derivatives, Thrombos. Haemostas.46, 270 (Abs.) (1981).